Ensuring access to essential medicines: some economic considerations.
Maskus
Keith E
KE
Development Economics Research Group, World Bank, University of Colorado at Boulder, USA.
D019380:Anti-HIV Agents / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D003906:Developing Countries; D016527:Drug Costs; D018954:Drugs, Essential / Q000191:economics* / Q000600:supply & distribution*; D005381:Financing, Organized; D015658:HIV Infections / Q000188:drug therapy; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D010330:Patents as Topic; D014376:Tuberculosis / Q000188:drug therapy
D019380:Anti-HIV Agents; D000995:Antitubercular Agents; D018954:Drugs, Essential